Identification of an Adenylyl Cyclase Inhibitor for Treating Neuropathic and Inflammatory Pain
- 12 January 2011
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 3 (65), 65ra3
- https://doi.org/10.1126/scitranslmed.3001269
Abstract
Neuropathic pain, often caused by nerve injury, is commonly observed among patients with different diseases. Because its basic mechanisms are poorly understood, effective medications are limited. Previous investigations of basic pain mechanisms and drug discovery efforts have focused mainly on early sensory neurons such as dorsal root ganglion and spinal dorsal horn neurons, and few synaptic-level studies or new drugs are designed to target the injury-related cortical plasticity that accompanies neuropathic pain. Our previous work has demonstrated that calcium-stimulated adenylyl cyclase 1 (AC1) is critical for nerve injury–induced synaptic changes in the anterior cingulate cortex. Through rational drug design and chemical screening, we have identified a lead candidate AC1 inhibitor, NB001, which is relatively selective for AC1 over other adenylate cyclase isoforms. Using a variety of behavioral tests and toxicity studies, we have found that NB001, when administered intraperitoneally or orally, has an analgesic effect in animal models of neuropathic pain, without any apparent side effects. Our study thus shows that AC1 could be a productive therapeutic target for neuropathic pain and describes a new agent for the possible treatment of neuropathic pain.Keywords
This publication has 58 references indexed in Scilit:
- Cellular and Molecular Mechanisms of PainCell, 2009
- Ca2+/Calmodulin-dependent Protein Kinase IV Links Group I Metabotropic Glutamate Receptors to Fragile X Mental Retardation Protein in Cingulate CortexPublished by Elsevier BV ,2009
- Plasticity of NMDA receptor NR2B subunit in memory and chronic painMolecular Brain, 2009
- Roles of the AMPA Receptor Subunit GluA1 but Not GluA2 in Synaptic Potentiation and Activation of ERK in the Anterior Cingulate CortexMolecular Pain, 2009
- FMRP Acts as a Key Messenger for Dopamine Modulation in the ForebrainNeuron, 2008
- Peripheral Mechanisms of Neuropathic Pain — Involvement of Lysophosphatidic Acid Receptor-Mediated DemyelinationMolecular Pain, 2008
- Signaling Pathways in Sensitization: Toward a Nociceptor Cell BiologyNeuron, 2007
- Understanding LTP in Pain PathwaysMolecular Pain, 2007
- Neuronal Mechanism for Neuropathic PainMolecular Pain, 2007
- cAMP detection methods in HTS: selecting the best from the restNature Reviews Drug Discovery, 2004